Invention Grant
- Patent Title: Mutant reverse transcriptase
-
Application No.: US15406160Application Date: 2017-01-13
-
Publication No.: US09932567B1Publication Date: 2018-04-03
- Inventor: Yan Xu , Jennifer Ong , Shengxi Guan , Nicole Nichols
- Applicant: New England Biolabs, Inc.
- Applicant Address: US MA Ipswich
- Assignee: New England Biolabs, Inc.
- Current Assignee: New England Biolabs, Inc.
- Current Assignee Address: US MA Ipswich
- Agency: New England Biolabs, Inc
- Agent Harriet M. Strimpel
- Main IPC: C12P19/34
- IPC: C12P19/34 ; C12N15/10 ; C12Q1/686 ; C12N9/22 ; C12N9/12 ; C12Q1/68

Abstract:
A mutant MMLV reverse transcriptase that may have an improvement in one or more properties is provided. For example, the present reverse transcriptase is believed to be more efficient relative to other commercially available MMLV reverse transcriptase variants, particularly for templates with a higher GC content.
Public/Granted literature
- US20180087036A1 Mutant Reverse Transcriptase Public/Granted day:2018-03-29
Information query